HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SkinMedica Expands Into Mineral Makeup With Addition of Colorescience

This article was originally published in The Rose Sheet

Executive Summary

Carlsbad, Calif-based SkinMedica seeks to capitalize on projected growth in the professional skin-care sector with the addition of Colorescience. The acquisition adds mineral makeup to SkinMedica’s portfolio of prescription and non-prescription skin-care products sold through doctors’ offices.

You may also be interested in...



In Brief

SkinMedica is acquired by BOTOX and Latisse maker Allergan for $350 million. NAD says BIC USA can support claims that its razors feature “flexible blades” following a challenge by Schick marketer Energizer Personal Care.

Professional Skin-Care Sales Projected To Outpace Market Through 2014

Though sales of professional skin-care products declined in the U.S. in 2009, the segment is expected to grow 5.6 percent annually through 2014, outpacing sales in the greater skin-care market, according to Kline Group's Karen Doskow

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel